Novel Coronavirus (SARS-CoV-2/COVID-19)
The AHA, joined by other organizations, urged the U.S. Supreme Court to review a 3rd Circuit Court of Appeals decision that gives private individuals “broad license” to bring meritless False Claims Act lawsuits against hospitals and other health care providers.
The Centers for Medicare & Medicaid Services April 10 issued a proposed rule for the inpatient psychiatric facility prospective payment system for fiscal year 2021. CMS proposes to increase IPF payments by a net 2.4%, equivalent to $100 million, in FY 2021.
The Centers for Medicare & Medicaid Services April 10 issued a proposed rule updating fiscal year 2021 payments for the skilled nursing facilities prospective payment system.
The National Institutes of Health launched a study to determine how many adults in the U.S. without a confirmed COVID-19 history have antibodies to the virus.
The American Medical Association released two Current Procedural Terminology codes (86328 and 86769) for reporting antibody testing for the novel coronavirus, and revised its CPT code for SARS-CoV-2 nucleic acid tests (86318).
To facilitate continuous patient care during quickly changing scenarios during the pandemic, the Drug Enforcement Administration has issued three exceptions to regulations for DEA-registered hospitals and clinics effective from April 10 until the public health emergency ends.
The Department of Health and Human Services announced updates to the process it launched last month for obtaining data on hospital bed capacity and utilization and COVID-19 testing results from in-house laboratories.
The Food and Drug Administration has issued emergency use authorizations for two respirator decontamination products.
The AHA urged the Department of the Treasury and the Federal Reserve to provide prompt guidance to help hospitals access the Main Street New Loan Facility created by the Coronavirus Aid, Relief, and Economic Security Act.
The AHA urged the Centers for Medicare & Medicaid Services to use its authority to extend to home health agencies additional relief to enhance their role in supporting and optimizing the overall health care system response to the COVID-19 pandemic.